• Plum IslandBill proposes sea mammal protection zone around Plum Island

    Three Long Island lawmakers on 1 June introduced a bill which would create a marine mammal and sea turtle protection zone around Plum Island and two other environmentally sensitive eastern Islands. The bill is expected to get a full vote in the legislature next week.

  • Plum IslandHouse temporarily halts sale of Plum Island

    New York and Connecticut lawmakers who have been campaigning against the sale of Plum Island by the federal government, have won an impressive victory as the U.S. House of Representatives voted unanimously on Monday to halt efforts to sell the property, at least temporarily. Plum Island, located of the north-eastern tip of Long Island, has for decades housed a high-security biolab in which research into deadly animal diseases pathogens. The aging lab is closing, and its operations will be moved to a modern high-security lab being built in the campus of Kansas State University.

  • view counter
  • Plum IslandPlum Island may be turned into a national park rather than sold to developers

    Members of the New York and Connecticut congressional delegations announced on Friday a plan to launch a study of Plum Island’s natural and historic resources, saying the plan is one step toward halting the sale of the island to developers. In 2009 DHS said the island would be sold to developers to help fund the new BioLab Level 4 on the campus of Kansas State University, which is set to open in 2022.

  • BiodefenseDHS S&T launches $100,000 prize competition to support NBAF facility

    DHS S&T announced the National Bio and Agro-Defense Facility (NBAF) Think and Do Challenge, a prize competition that seeks ideas to leverage NBAF resources in order to conduct research to protect the nation’s animal agricultural industry and public health. S&T says that it will award up to $100,000 to help fund the development or implementation of winning submissions through the NBAF Think and Do Challenge, under the authority of the America COMPETES Act.

  • Synthetic biologyU.S. defense agencies dominate federal synthetic biology research

    A new analysis finds the Defense Department and its Defense Advanced Research Projects Agency (DARPA) fund much of the U.S. government’s research in synthetic biology, with less than 1 percent of total federal funding going to risk research. Between 2008 and 2014, the United States invested approximately $820 million dollars in synthetic biology research. In that time period, the Defense Department became a key funder of synthetic biology research. DARPA’s investments, for example, increased from near zero in 2010 to more than $100 million in 2014 — more than three times the amount spent by the National Science Foundation (NSF).

  • BiolabsNew book details safety, security methods for biosciences sites

    Recent mishaps at laboratories which mishandled potentially dangerous biological substances and the transmission of the Ebola virus in a U.S. hospital are symptoms at bioscience facilities that two Sandia National Laboratories researchers think could be prevented by implementing the practices in a new book on biorisk management. The new book, Laboratory Biorisk Management: Biosafety and Biosecurity, is the first full-length manuscript on the detailed implementation of biorisk management.

  • Biolabs cybersecurity Researchers carefully protect dangerous pathogens – but how secure are all their data?

    By Carole Baskin

    Ebola, smallpox, anthrax and many others: the most dangerous microorganisms are strictly regulated in the United States. The federal government oversees use of sixty-five so-called select agents with “the potential to pose a severe threat to public, animal or plant health, or to animal or plant products.” There has never been as much research performed with these pathogens —to learn more, find cures, or create vaccines — as in the past decade. The sprawl of high containment laboratories has led to a parallel increase in individuals with access to these agents. As of January 2015, approximately 11,000 individuals were on the list. The deadly infectious agents must be kept safely under lock and key, where they can’t threaten the general population or fall into the wrong hands. But even the most physically secure research lab could be the site of a devastating data security breach. As they stand now, information security guidelines published by science regulators with regard to select agents lack the critical level of detail needed to protect data effectively.

  • BiolabsCDC to review oversight of bioterror labs as concerns grow over lax supervision

    Tom Frieden, the director of the CDC, has ordered a review of how the agency oversees and implements safety and security measures in bioterror laboratories across the country. Documents obtained through FOIA request show that dozens of labs handling the most dangerous bioterror pathogens have time and again failed to comply with key safety and security measures, but CDC inspectors allowed these labs to operate for years before offering to put them on a “performance improvement” plan. Even when inspectors identified significant violations of safety or security practices in work with “Tier 1” select agents – the deadliest of bioterror weapons — the agency only “strongly recommend[ed]” the labs stop work with the pathogens, but without mandating it.

  • BiolabsLawmakers demand answers on labs’ handling of deadly pathogens

    The leaders of the House Energy and Commerce Committee from both parties yesterday sent a letter to the Inspector General of the Department of Health and Human Services demanding answers regarding the Federal Select Agent Program (FSAP). “Select agents” is the term used by the government for viruses, bacteria, and toxins that could be used by terrorists. The committee members directed ten questions to the HHS IG in an effort to learn details about labs that have been fined or faced other enforcement actions, including suspension or revocation of their federal authorizations to work with select agents. “So far we’ve been lucky, but that luck may run out if we don’t get the system fixed,” said Representative Frank Pallone Jr. (D-New Jersey).

  • BiosafetySafety concerns dog new Level 4 Biolab being built in the middle of Tornado Alley

    The new Department of Homeland Security’s(DHS) animal pathogen-research facility, a Level 4 Biolab being built in Manhattan, Kansas and aiming to replace the aging New York’s Plum Island lab, is situated in the middle of Tornado Alley, leading researchers and security experts to question the wisdom of the decision to build it there. Why place a lab in which research is conducted on pathogens for which no cure or treatment has yet been found – fir example, foot-and-mouth disease – not only in an area known for being routinely hit by powerful tornadoes, but also in the middle of a region where most U.S. cattle is being raised?

  • AnthraxNo government agency oversees handling of deadly pathogens in 1,495 U.S. labs

    According to the CDC, 181 “organizations or entities” in the United States are registered as working with live anthrax, and 321 in total working with live pathogens. Within these 321 entities, roughly 1,495 laboratories are accredited under the Federal Select Agent Program to work with live pathogens such as anthrax. There is no official government agency to oversee production and research of bioweapons that does not – as the CDC does — engage in its own active pathogen research. “Even one spore is a sufficient seed stock from which an amount could grow to mount a biological weapons attack,” says one expert. “The sad circumstance is that this massive effort [U.S. research on anthrax] since 2001 has dramatically increased the chances of a biological weapon attack on the U.S., precisely by distributing a highly lethal strain of the agent with no structure and no ability to record where they have gone.”

  • AnthraxPentagon, CDC investigating live anthrax shipping mishap

    Pentagon chief Ashton Carter has announced that the Department of Defense, in collaboration with the Centers for Disease Control and Prevention (CDC), is investigating the recent accidental shipment from a U.S. Army laboratory in Utah of live bacterium anthrax samples to fifty-one facilities in eighteen states and three foreign countries. The investigators have already identified the West Desert Test Center (WDTC), the testing area for Dugway Proving Ground, as the source of the mix up.

  • Bioweapons51 labs in 17 states may have received live anthrax samples: Pentagon

    Deputy Secretary of Defense Robert Work said yesterday (Wednesday) that the Pentagon may have shipped live anthrax samples to fifty-one labs in seventeen states and the District of Columbia, as well as three foreign countries. Word also said that it was likely that the numbers of labs which might have received live anthrax will go up as the Pentagon’s investigation into the shipments continues. All the samples shipped belonged to three lots, dating back to 2007, stored at the Dugway Proving Ground in Utah. CDC raises questions about the effectiveness of the method used by the Dugway lab to deactivate anthrax spores.

  • BioweaponsPentagon accidentally ships live anthrax from Utah to labs in nine states

    The U.S. Department of Defense yesterday admitted it had accidentally shipped samples of a live anthrax spores – a potential bioweapon — across nine states and to a U.S. air base in South Korea. The Pentagon revealed what it described as an “inadvertent transfer of samples containing live Bacillus anthracis” from a DoD laboratory in Dugway Proving Ground, Utah to labs in nine states. The mishap alarmed biosafety experts. “These events shouldn’t happen,” said one.

  • BiolabsGroundbreaking for new Biosafety Level 4 lab in Kansas

    Officials on Wednesday broke ground for the National Bio and Agro-Defense Facility (NBAF), a $1.25 billion animal research facility near the campus of Kansas State University in Manhattan, Kansas. NBAF will be the U.S. only Level 4 biosafety lab – a designation which means that the lab is secure enough to handle, and conduct research on, pathogens that do not currently have treatments or countermeasures. Critics argue that locating the lab on the campus of KSU — in the heart of cattle country and the middle of Tornado Alley – would not be a good idea. NBAF will replace the aging biolab in Plum Island, New York.